3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Lung Neoplasms
2
Recurrence
1
Non-Small Cell Lung Cancer ALK-positive
1
Neurofibromatosis 1
1
Neoplasm Metastasis
1
Meningeal Carcinomatosis
1
Hereditary Sensory and Autonomic Neuropathies
1
Glioma
1
Glioblastoma
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Neoplasms
1
Brain Neoplasms
1
Astrocytoma
1
Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
1
Advanced Non-Small Cell Lung Cancer
1
ALK Positive Non-small Cell Lung Cancer
1
Interventions
Magnetic Resonance Spectroscopy
5
Cyclophosphamide
5
dinutuximab
3
Topotecan
3
Etoposide
3
Doxorubicin
3
Carboplatin
3
Biopsy
3
sargramostim
2
Vincristine
2
Thiotepa
2
Stem Cell Transplantation
2
Specimen Handling
2
Radiation
2
Platinum
2
Melphalan
2
Isotretinoin
2
Colony-Stimulating Factors
2
Cisplatin
2
1,2-diaminocyclohexaneplatinum II citrate
2
iberdomide
1
gallium Ga 68 dotatate
1
fludarabine
1
Watchful Waiting
1
Transurethral Resection of Bladder
1
Temozolomide
1
Razoxane
1
Radiotherapy
1
Proton Therapy
1
Observation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ganglioneuroblastoma
×
lorlatinib
×
90 days
×
Clear all
No trials found.